These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6590905)

  • 1. [The fifth report on the survey of adverse reactions to radiopharmaceuticals (the 8th survey in 1982)].
    Kaku Igaku; 1984 Mar; 21(3):283-7. PubMed ID: 6590905
    [No Abstract]   [Full Text] [Related]  

  • 2. [The fourteenth report on survey of the adverse reaction to radiopharmaceuticals (the 17th survey in 1991). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1993 May; 30(5):575-81. PubMed ID: 8336418
    [No Abstract]   [Full Text] [Related]  

  • 3. [The 35th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 38th Survey in 2012)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M; ;
    Kaku Igaku; 2014 Feb; 51(1):1-12. PubMed ID: 24765821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The seventeenth report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 20th survey in 1994). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee. Japan Radioisotope Association].
    Kaku Igaku; 1996 Jun; 33(6):675-86. PubMed ID: 8741514
    [No Abstract]   [Full Text] [Related]  

  • 5. [Survey on adverse reactions to radiopharmaceuticals: Report No. 3 (the 6th survey in 1980)].
    Kaku Igaku; 1982 Aug; 19(7):1099-105. PubMed ID: 6757501
    [No Abstract]   [Full Text] [Related]  

  • 6. [The tenth report on survey of the adverse reaction to radiopharmaceuticals (the 13th survey in 1987). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1989 Apr; 26(4):565-72. PubMed ID: 2770047
    [No Abstract]   [Full Text] [Related]  

  • 7. [The eleventh report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 14th survey in 1988). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1991 Mar; 28(3):323-8. PubMed ID: 2046189
    [No Abstract]   [Full Text] [Related]  

  • 8. [The fifteenth report on survey of the adverse reaction to radiopharmaceuticals (the 18th survey in 1992). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1994 Mar; 31(3):289-96. PubMed ID: 8176869
    [No Abstract]   [Full Text] [Related]  

  • 9. [The second report on survey of the adverse reaction to radiopharmaceuticals in Japan (author's transl)].
    Kaku Igaku; 1981 Apr; 18(3):415-9. PubMed ID: 7277886
    [No Abstract]   [Full Text] [Related]  

  • 10. [The thirteenth report on survey of the adverse reaction to radiopharmaceuticals (the 16th survey in 1990). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1992 Mar; 29(3):399-405. PubMed ID: 1583811
    [No Abstract]   [Full Text] [Related]  

  • 11. [The sixth report on survey of the adverse reaction to radiopharmaceuticals (the 9th survey in 1983)].
    Kaku Igaku; 1985 Apr; 22(4):551-5. PubMed ID: 4010078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survey of the adverse reaction to radiopharmaceuticals in Japan (author's transl)].
    Kaku Igaku; 1979 May; 16(3):511-6. PubMed ID: 480724
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Sixteenth Report on Survey of the Adverse Reactions to Radiopharmaceuticals (the 19th survey in 1993)].
    Kaku Igaku; 1995 Jun; 32(6):605-13. PubMed ID: 7674572
    [No Abstract]   [Full Text] [Related]  

  • 14. [The twenty-first report on survey of the adverse reaction to radiopharmaceuticals (the 24th survey in 1998). Subcommittee of Safety Issue for the Radiopharmaceuticals. Medical and Pharmaceutical Committee. Japan Radioisotope Association].
    Kaku Igaku; 2000 May; 37(3):237-48. PubMed ID: 10860354
    [No Abstract]   [Full Text] [Related]  

  • 15. [The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005)].
    Kusakabe K; Arano Y; Okamura T; Kasagi K; Komatani A; Matsuda H; Maruno H; ; ;
    Kaku Igaku; 2007 Feb; 44(1):29-42. PubMed ID: 18240581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)].
    Kusakabe K; Okamura T; Kasagi K; Komatani A; Sato Y; Matsuda H; Maruno H; ;
    Kaku Igaku; 2006 Feb; 43(1):23-35. PubMed ID: 16634540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the use of CA-125 in gynecologic mass screening].
    Nakatani K; Hoshiai H; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):157-60. PubMed ID: 3469285
    [No Abstract]   [Full Text] [Related]  

  • 18. [The 33rd report on survey of the adverse reaction to radiopharmaceuticals (the 36th Survey in 2010)].
    Matsuda H; Arano Y; Okazawa H; Okamura T; Mizumura S; Yokoyama K; ; ;
    Kaku Igaku; 2012 Feb; 49(1):1-14. PubMed ID: 22624452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum carbohydrate antigen 19.9 in patients with digestive cancers].
    Encabo G; Genolla J; Gefaell R; Ruibal A
    Presse Med; 1985 Dec; 14(45):2304. PubMed ID: 2935826
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new carbohydrate antigen CA 19-9 associated with malignancies of digestive system. I. Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Yamanaka T; Kimura K; Yagisawa K; Igarashi S; Yonezawa M; Ioku A
    Rinsho Byori; 1984 May; 32(5):539-45. PubMed ID: 6592377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.